Page last updated: 2024-10-15

3-hydroxyanthranilic acid and Carcinoma, Non-Small Cell Lung

3-hydroxyanthranilic acid has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

3-Hydroxyanthranilic Acid: An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen.
3-hydroxyanthranilic acid : An aminobenzoic acid that is benzoic acid substituted at C-2 by an amine group and at C-3 by a hydroxy group. It is an intermediate in the metabolism of the amino acid tryptophan.
3-hydroxyanthranilate : A hydroxybenzoate that is the conjugate base of 3-hydroxyanthranilic acid.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Karayama, M1
Masuda, J1
Mori, K1
Yasui, H1
Hozumi, H1
Suzuki, Y1
Furuhashi, K1
Fujisawa, T1
Enomoto, N1
Nakamura, Y1
Inui, N1
Suda, T1
Maekawa, M1
Sugimura, H1
Takada, A1

Other Studies

1 other study available for 3-hydroxyanthranilic acid and Carcinoma, Non-Small Cell Lung

ArticleYear
Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:2

    Topics: 3-Hydroxyanthranilic Acid; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; Biomarkers; Carcinoma, Non

2021